Drug
TLL-018
TLL-018 is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
2
50%
Ph phase_2
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Terminated(1)
Detailed Status
Withdrawn1
Recruiting1
Active, not recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 22 (50.0%)
Phase 32 (50.0%)
Trials by Status
withdrawn125%
recruiting125%
active_not_recruiting125%
completed125%
Recent Activity
2 active trials
Showing 4 of 4
active_not_recruitingphase_3
A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs
NCT06020144
recruitingphase_3
A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis
NCT06887127
completedphase_2
The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis
NCT05133297
withdrawnphase_2
Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis
NCT05121402
Clinical Trials (4)
Showing 4 of 4 trials
NCT06020144Phase 3
A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs
NCT06887127Phase 3
A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis
NCT05133297Phase 2
The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis
NCT05121402Phase 2
Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4